Is chemotherapy a good option for my advanced prostate cancer? APC experts, Dr. Russell Szmulewitz, Dr. Emmanuel Antonarakis, Malecare Director, Joel Nowak, and moderator, Dr. Tomasz Beer, discuss the efficacy of chemotherapy for prostate cancer patients. The panel shares information on quality of life studies and TUPOR...
Read More
Hormonal therapy—also known as androgen deprivation therapy—has long been used to treat prostate cancer. But how does it work? And what are the potential side effects? Prostate cancer experts Drs. Jeri Kim and Sumit K. Subudhi, from MD Anderson Cancer Center, explore approved hormonal therapy...
Read More
What are the common side effects of advanced prostate cancer treatment, and how can they be managed? An expert panel—including Dr. Jeri Kim, Dr. Sumit Subudhi and Zita Dubauskas Lim—shares an overview of side effects associated with hormonal therapies, chemotherapy and immunotherapy. Published By : Patient Power Date : Aug 18,...
Read More
How does prostate cancer work? With Andrew Schorr as host, Dr. Russell Szmulewitz of the University of Chicago Medical Center gives a short description of the endocrinology of prostate cancer and provides an overview of hormonal therapies. Listen as Dr. Szmulewitz examines the changing treatment paradigm including risks and...
Read MoreHow do I manage my side effects for better quality of life? Patient Power founder and host, Andrew Schorr, facilitates a dialogue between advanced prostate cancer experts, Dr. William Catalona, Dr. Russell Szmulewitz of University of Chicago Medical Center, and Judith Paice, PhD, RN to discuss managing and communicating treatment side effects. ...
Read More
Why do patients choose certain treatment options and therapies over others? When should a patient choose surgery, chemotherapy, immunotherapy, etc.? Drs. Sapna Patel, Michael Wong and Mark Gimbel discuss how surgery is always the first thought of treatment, as it is much more ideal to extract the cancerous area. However, as history has shown, some...
Read More
Prognostic factors, including blood tests and radiographic scans, can help establish a patient’s prognosis and determine a treatment path. Experts from MD Anderson Cancer Center, Drs. Jeri Kim and Sumit Subudhi, review factors that are associate with prostate cancer and discuss research underway that could lead to more personalized...
Read More
Patient advocate Jeff Folloder conducts an in-depth discussion on emerging immunotherapy approaches for advanced prostate cancer with MD Anderson Cancer Center experts, Dr. Sumit Subudhi and Dr. Jeri Kim. Walking us through developing treatments, including vaccines and checkpoint inhibitors/immune modulators, these experts refer to today as...
Read More
Diagnosed with advanced prostate cancer at age 53, Joe felt like he was hit by a Mac truck and prepared for the worst. Now, five years later, Joe is doing well and his PSA is undetectable. Joe and his wife, Yolanda, share their story and explain the tools that helped Joe move past the initial fear of his diagnosis. Transcript Please...
Read MoreTargeted treatment for breast cancer through external beam radiation is offering hope for those newly diagnosed with the disease. Dr. Christine Fang, radiation oncologist at the Seattle Cancer Care Alliance, details how this important approach allows for greater precision during radiation, offers protection for the heart and great benefit for...
Read More
How does a diagnosis of prostate cancer affect intimacy? Led by patient advocate Jeff Folloder, experts across several disciplines discuss sexuality and dysfunction. The panel explores how, in one form or another, this subject affects every single advanced prostate cancer patient and his partner. Learn how communication and support through...
Read More
On location at the World Conference on Lung Cancer (WCLC), we caught up with Dr. Edward Kim, Chair of the Solid Tumor Oncology Investigational Therapy Department at Carolina's Levine Cancer Institute. Dr. Kim highlighted three of the most exciting changes occurring in the lung cancer field: new options and tools for patients, updated tumor...
Read More
